Ligustrazine modulates intestinal flora in atherosclerotic rats by regulating the TLR4/MyD88/NF-κB signaling pathway

Ligustrazine modulates intestinal flora in atherosclerotic rats by regulating the TLR4/MyD88/NF-κB signaling pathway

ZHAO Kun, LIU Ming, JI Wenyan, ZHANG Lu

PDF(8522 KB)

Welcome to Current Immunology, Today is

PDF(8522 KB)

Current Immunology ›› 2026, Vol. 46 ›› Issue (2) : 160-168.

Ligustrazine modulates intestinal flora in atherosclerotic rats by regulating the TLR4/MyD88/NF-κB signaling pathway

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 46(2): 160-168

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(8522 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉